Prime Capital Investment Advisors, LLC Biogen Inc. Transaction History
Prime Capital Investment Advisors, LLC
- $6.63 Billion
- Q2 2024
A detailed history of Prime Capital Investment Advisors, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Prime Capital Investment Advisors, LLC holds 10,280 shares of BIIB stock, worth $2.04 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
10,280
Previous 12,136
15.29%
Holding current value
$2.04 Million
Previous $2.62 Million
8.91%
% of portfolio
0.04%
Previous 0.04%
Shares
9 transactions
Others Institutions Holding BIIB
# of Institutions
1,050Shares Held
128MCall Options Held
1.22MPut Options Held
1.4M-
Vanguard Group Inc Valley Forge, PA16.6MShares$3.29 Billion0.08% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$3.24 Billion2.78% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.88 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.1MShares$1.41 Billion0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.68MShares$1.13 Billion0.83% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $28.5B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...